The inspiring story of Emma Betts premieres on Australian Story
16 April 2018
Emma Betts was only 22 years old when she learned that she had stage 4 melanoma. Emma shared her story with many by documenting her experience with melanoma on her blog Dear Melanoma. She sadly passed away at the age of 25 in April, 2017.
Australian Story's 'Dear Emma' is a tribute to the life and times of a young woman determined to raise awareness about melanoma. A true tear-jerker, the segment will explore how Emma and her husband Serge dealt with her heartbreak and how her parents Tamra and Leon, are continuing Emma’s legacy of encouraging others to contribute to life-saving research.
Although Emma was not a patient of Melanoma Institute Australia, she cared very deeply about people with melanoma and people at risk of melanoma around the country. She did everything she could to get the word out and raised a lot of funds for research at MIA - which reveals the complexity of the drivers of melanoma in younger people. It's not only about sun damage.
We're committed to weaving Emma's loving legacy into the work we'll be undertaking to draw attention to melanoma in young Australians and the research, treatment and education strategies we need to stop losing them to this disease.
Emma Betts started the national conversation about melanoma that Australia has to have. To continue Emma’s legacy, we need to keep that conversation going.
You can honour Emma's passion for life-saving research by making a donation here.
Watch Australian Story's Dear Emma on Monday, 16 April at 8pm on ABC TV and ABC iview
Melanoma Institute Australia Launches Free e-learning Education Portal
Melanoma Institute Australia (MIA) has launched a free e-learning portal to educate healthcare professionals about the latest advances in melanoma diagnosis and treatment.
David Day and a lifetime of missed moments
When David lost his life last year, he was 33, with three daughters under six.
Australian melanoma experts share latest breakthroughs with world's best oncologists
ASCO 2018 brings together the world's best in oncology from around the world.
ASCO 2018 – the important role of clinical trials
Clinical trials are just that – trials in a clinical setting to evaluate the effectiveness or otherwise of individual and combination treatments.
MIA Scoops Awards at the International Academy of Pathology
Melanoma Institute Australia scooped the award pool at the Annual Scientific Meeting of the International Academy of Pathology.
Evidence drives sweeping changes to melanoma treatment recommendations
Melanoma patients across Australia will benefit from the release of updated clinical care guidelines.
Melanoma and Marital Status: A Study
An American study has discovered a link between early detection and marital status in melanoma diagnosis.
A weekend in Paris talking all things pathology...
An international course on melanoma pathology in Paris, France co-directed by Professor Richard Scolyer took place over the weekend.
Our own 'Australian Story'
Professor Richard Scolyer highlights the difficulties of diagnosis following the Australian Story feature program on Emma Betts.
Cancer Australia releases 'stage at diagnosis' data for top five incidence cancers – including melanoma
For the first time in Australia, national data has been released on cancer stage at diagnosis. This data explores the top five incidence cancers – female breast cancer, colorectal, lung, prostate cancers and melanoma.
The inspiring story of Emma Betts premieres on Australian Story
'Dear Emma' - a tribute to the life and times of a young woman determined to raise awareness about melanoma.
Toyota helps tackle Australia's national cancer - melanoma
Carole Renouf, CEO for MIA thanks Toyota for helping fuel ongoing melanoma research.
Tackling the Kokoda Trail for melanoma
Fraser Dykes tackled the Kokoda Trail on an eight day trek in memory of his friend Mark 'Bod' Boddison.
Professor Richard Scolyer presents at world's largest annual meeting of pathologists
Harvard’s Clinical Professor Martin Mihm and MIA’s Conjoint Medical Director Professor Richard Scoyler delivered a series of lectures on melanoma pathology in Vancouver, British Colombia this week at the world’s biggest annual pathology meeting.
Farewell from Carole Renouf, CEO of Melanoma Institute Australia
A message from our CEO, Carole Renouf
Marching in the twilight
Piction, Brisbane, Bahturst and Port Macquarie march to end melanoma.
Researchers uncover treatment sequence for advanced melanoma patients
Australian researchers have greater clarity on the best course of treatment for patients with advanced melanoma which has spread to the brain.
An unsung hero of melanoma care for nearly 30 years
Melanoma treatment has come a long way in recent times, and the role that nurses play caring for melanoma patients has changed dramatically too.
Sharing our research on melanoma surgery
MIA is sharing it's research with the global surgical oncology community this week at the Society of Surgical Oncology Annual Cancer Symposium.